Skip to main content
. 2023 Mar 28;10(4):430. doi: 10.3390/bioengineering10040430

Figure 4.

Figure 4

(A) The docked complex of LSDV-V2. TLR4 immune receptor is shown in blue while red represents the LSDV-V2 vaccine construct. (B) Interacting residues between TLR4 (chain A) and vaccine construct (chain B).